Free Trial
TSE:HBP

Helix BioPharma (HBP) Stock Price, News & Analysis

Helix BioPharma logo
C$0.85 0.00 (0.00%)
As of 11/13/2026

About Helix BioPharma Stock (TSE:HBP)

Advanced

Key Stats

Today's Range
C$0.85
▼
C$0.85
50-Day Range
C$0.82
▼
C$1.80
52-Week Range
C$0.75
▼
C$2.60
Volume
N/A
Average Volume
4,387 shs
Market Capitalization
C$64.92 million
P/E Ratio
N/A
Dividend Yield
1.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Helix BioPharma Corp. is a clinical-stage oncology company focused on developing therapies for underserved patient populations with difficult-to-treat cancers. The Company's pipeline is led by L-DOS47, a clinical-stage antibody-enzyme conjugate being developed as a combination therapy for non-small cell lung cancer (NSCLC). Additional pipeline candidates include LEUMUNA¿, a pre-IND oral immune checkpoint modulator for post-transplant leukemia relapse, and GEMCEDA¿, a pre-IND gemcitabine prodrug for advanced solid tumors.

Receive HBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HBP Stock News Headlines

Helix BioPharma : YE 2026 Financial statements
My public warning after 55 years of watching the markets
Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.tc pixel
Off-market insider selling at Helix BioPharma (HBP)
HBP.TO - | Stock Price & Latest News | Reuters
See More Headlines

HBP Stock Analysis - Frequently Asked Questions

Helix BioPharma's stock was trading at C$2.37 on January 1st, 2026. Since then, HBP stock has decreased by 64.1% and is now trading at C$0.85.

Helix BioPharma Corp. (TSE:HBP) issued its quarterly earnings results on Friday, October, 30th. The biopharmaceutical company reported C($0.01) EPS for the quarter.

Shares of HBP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Company Calendar

Last Earnings
10/30/2026
Today
11/15/2026

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
TSE:HBP
CIK
N/A
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$50.55 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-22.23%
Return on Assets
-279.98%

Debt

Debt-to-Equity Ratio
29.27
Current Ratio
0.19
Quick Ratio
1.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
C$0.08 per share
Price / Cash Flow
11.32
Book Value
C$0.19 per share
Price / Book
4.57

Miscellaneous

Outstanding Shares
76,378,000
Free Float
N/A
Market Cap
C$64.92 million
Optionable
Not Optionable
Beta
1.39
The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (TSE:HBP) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners